Abstract B119: A DNA plasmid melanoma cancer vaccine, SCIB1, combined with nivolumab + ipilimumab induces functional CD4 and CD8 T cell responses in patients with advanced unresectable melanoma
Year: 2025
Type: conference-abstract
Source: Cancer Immunology Research
Authors: Joseph Chadwick, Gaëlle Cane, Sabaria Shah, Katie Mann, Patrick Copeland, Daisy Weston, Jordan Wright, Leanne Toon, Heather Shaw, Poulam Patel, Miranda Payne, Satish Kumar, Sarah Danson, Martin Highley, Clare Barlow, Kellati Prasad, Ioannis Karydis, Maria Marples, Kate Young, Pippa Corrie, Robert Miller, Rachael Metheringham, Georgia Goodhew, Nermeen Varawalla, Samantha Paston, Lindy Durrant
Institutions: Mount Vernon Cancer Centre, Nottingham University Hospitals NHS Trust, Churchill Hospital, University of Oxford, Velindre NHS Trust, Velindre Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, University of Sheffield, Derriford Hospital, University Hospitals Plymouth NHS Trust, Musgrove Park Hospital, Taunton & Somerset NHS Foundation Trust, Somerset NHS Foundation Trust, Royal Preston Hospital, Southampton General Hospital, Leeds Teaching Hospitals NHS Trust, St James's University Hospital, Royal Marsden Hospital, Addenbrooke's Hospital
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4407866577